MPZ-, GDAP1-, and NEFL-Related Charcot-Marie-Tooth Disease with Diverse Clinical and Electrophysiological Phenotypes
Open Access
- 31 December 2022
- journal article
- review article
- Published by Korean Association of EMG Electrodiagnostic Medicine in Journal of Electrodiagnosis and Neuromuscular Diseases
- Vol. 24 (3) , 62-69
Abstract
Charcot-Marie-Tooth disease (CMT) is a spectrum of clinically and genetically heterogeneous peripheral neuropathies. CMT can be classified into demyelinating, intermediate, or axonal neuropathy based on clinical, histopathological, and electrophysiological findings. Approximately 140 genes have been reported to be associated with CMT. Mutations in the myelin protein zero (MPZ), ganglioside-induced differentiation related protein 1 (GDAP1), and neurofilament light-chain polypeptide gene (NEFL) genes have been reported to cause all three types of CMT, which is noteworthy because most CMT-related genes cause a single type of neuropathy (either demyelinating or axonal). In contrast, it remains unclear why these genes cause several types of CMT. CMT is presently incurable; however, ongoing attempts to treat CMT with various drugs and dietary supplements have increased the importance of an exact genetic diagnosis for precision medicine. Therefore, it is important to identify the causative mutations and compare the associated clinical characteristics. Taken together, a comparison of causative mutations and clinical features of patients with MPZ, GDAP1, and NEFL mutations will be the first step in understanding how different types of CMT are caused, and will enable a molecular genetic diagnosis. In this review, we describe the clinical, electrophysiological, and genetic characteristics of MPZ-, GDAP1-, and NEFL-related CMT.Keywords
This publication has 44 references indexed in Scilit:
- Diagnostic laboratory testing for Charcot Marie Tooth disease (CMT): the spectrum of gene defects in Norwegian patients with CMT and its implications for future genetic test strategiesBMC Medical Genetics, 2013
- Charcot-Marie-Tooth disease: Frequency of genetic subtypes in a German neuromuscular center populationNeuromuscular Disorders, 2013
- Charcot–Marie–Tooth disease: frequency of genetic subtypes and guidelines for genetic testingJournal of Neurology, Neurosurgery & Psychiatry, 2012
- Charcot-Marie-Tooth-related Gene GDAP1 Complements Cell Cycle Delay at G2/M Phase in Saccharomyces cerevisiae fis1 Gene-defective CellsJournal of Biological Chemistry, 2011
- Charcot‐marie‐tooth disease subtypes and genetic testing strategiesAnnals of Neurology, 2011
- Identification and in silico analysis of 14 novel GJB1, MPZ and PMP22 gene mutationsEuropean Journal of Human Genetics, 2009
- Neurofilament light chain polypeptide gene mutations in Charcot–Marie–Tooth disease: nonsense mutation probably causes a recessive phenotypeJournal of Human Genetics, 2009
- Charcot-Marie-Tooth disease type 1B: marked phenotypic variation of the Ser78Leu mutation in five Italian familiesActa Neurologica Scandinavica, 2008
- Novel mutation in the myelin protein zero gene in a family with intermediate hereditary motor and sensory neuropathyJournal of Neurology, Neurosurgery & Psychiatry, 1999
- Spectrum of mutations in Finnish patients with Charcot-Marie-Tooth disease and related neuropathiesHuman Mutation, 1998